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Abstract
Obesity is a growing epidemic characterized by excess fat storage in adipocytes. Although lipoprotein receptors play important
roles in lipid uptake, their role in controlling food intake and obesity is not known. Here we show that the lipoprotein receptor
LRP1 regulates leptin signaling and energy homeostasis. Conditional deletion of the Lrp1 gene in the brain resulted in an obese
phenotype characterized by increased food intake, decreased energy consumption, and decreased leptin signaling. LRP1
directly bindstoleptin and the leptinreceptorcomplexand isrequiredforleptin receptor phosphorylationandStat3activation.
We further showed that deletion of the Lrp1 gene specifically in the hypothalamus by Cre lentivirus injection is sufficient to
trigger accelerated weight gain. Together, our results demonstrate that the lipoprotein receptor LRP1, which is critical in lipid
metabolism, also regulates food intake and energy homeostasis in the adult central nervous system.
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Introduction
The low-density lipoprotein receptor-related protein 1 (LRP1) is a
large cell surface receptor ubiquitously expressed in a variety of
organs including adipose tissue, liver, and brain [1]. Previous tissue-
specific knockout studies showed that hepatic LRP1 mediates the
metabolism of apolipoprotein E (apoE)-rich chylomicron remnants
[2] and that adipocyte LRP1 modulates postprandial lipid transport
and glucosehomeostasis [3].Furthermore, LRP1has a pivotal role in
preventing atherosclerosis by restricting smooth muscle cell prolifer-
ation and protecting vascular wall integrity [4]. In the central nervous
system (CNS), LRP1 is highly expressed in neurons and plays critical
roles in lipoprotein metabolism, neurotransmission, synaptic plastic-
ity, cell survival, and clearance of the amyloid-b (Ab) peptide, critical
in the pathogenesis of Alzheimer’s disease (AD) [5–7].
Results and Discussion
Neuronal Deletion of Lrp1 in the Adult Mouse Brain Leads
to Obesity
To investigate the roles of LRP1 in the adult CNS, we
generated conditional Lrp1 forebrain knockout mice (LRP1-KO)
by crossing Lrp1 floxP mice [2] with aCamKII-Cre mice [8].
Because aCamKII-Cre is only expressed in neurons of the adult
brain [8], the essential function of LRP1 during embryonic
development [9] is preserved. Lrp1 deletion in different brain
regions was assessed by comparing LRP1 protein expression levels
between LRP1-KO (Lrp1
flox+/+/Cre
+/2, LRP1 knockout) and WT
(Lrp1
flox+/+/Cre
2/2, Lrp1 floxP littermate control) mice at 3, 6, 9,
and 12 mo of age. LRP1 expression was not significantly decreased
in the LRP1-KO mice at 3 mo of age. However, from 6 to 12 mo
of age, LRP1 expression was decreased by ,75% in the cortex,
hypothalamus, and hippocampus of LRP1-KO mice (Figure S1A–
S1C). The residual LRP1 observed in these regions likely
represents LRP1 expressed in glial cells [10]. Inactivation of the
Lrp1 gene was specific to the forebrain, as no changes in LRP1
expression were detected in the cerebellum or in peripheral tissues
(Figure S1D and S1E).
LRP1-KO mice were apparently indistinguishable from control
littermates during the first 6 mo of life but showed significantly
accelerated body weight gain starting at 7 mo of age (Figure 1A
and S2A). This increased weight gain in LRP1-KO mice
correlated closely with the observed decrease in LRP1 expression
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obese at about 12 mo of age (Figure 1B) and had approximately 2-
fold increased body fat content compared to their littermate
controls (Figure 1C). No changes in snout-anus length between
LRP1-KO mice and WT mice were observed (Figure S2B). LRP1-
KO mice ate significantly more than controls (Figure 1D) and had
significantly decreased energy expenditure, as revealed by
decreased O2 consumption and CO2 production (Figure 1E and
1F). Together, these results indicated that LRP1 expression in the
brain controls body weight and adiposity by regulating food intake
and energy expenditure.
Obesity in LRP1-KO mice was associated with hyperlipidemia
and insulin resistance. LRP1-KO mice showed a 3-fold increase in
circulating free fatty acids (FFA) and ,50% increase in circulating
triglycerides (TG) (Figure 1G and 1H). Plasma cholesterol levels
were not significantly altered in LRP1-KO mice (Figure 1I). At
about 12 mo of age, LRP1-KO mice showed approximately 2-fold
increase in plasma insulin levels (Figure 1J). While fasting blood
glucose levels appeared to be normal (unpublished data), LRP1-
KO mice had significantly decreased tolerance to exogenous
glucose when assessed by intraperitoneal glucose tolerance test
(GTT). A marked increase in both magnitude and duration of
blood glucose in response to glucose injection was observed in
LRP1-KO mice (Figure 1K). LRP1-KO mice also failed to reduce
blood glucose levels after insulin injection (insulin tolerance test,
ITT) (Figure 1L). Thus, the obese phenotype in LRP1-KO mice
was characterized by hyperlipidemia and insulin resistance,
resembling the metabolic syndrome pathology in humans.
LRP1 Regulates Leptin Signaling
Increase in fat storage observed in LRP1-KO mice was
accompanied by approximately 5-fold increase in plasma leptin
concentrations (Figure 1M). Because leptin secreted by adipose
tissue plays a major role in body weight regulation [11–13], we
hypothesized an existing leptin-resistant condition in LRP1-KO
mice. To directly assess a role for LRP1 in leptin signaling we
measured the levels of phospho-Stat3 (P-Stat3) [14] in the
hypothalamus of LRP1-KO and WT mice. A significant decrease
in the levels of P-Stat3 was observed in LRP1-KO mice (Figure 2A,
2B and S2C, S2D). In addition, deletion of LRP1 in the adult
brain led to leptin insensitivity as shown by impaired leptin-
stimulated phosphorylation of hypothalamic Stat3 (Figure 2C and
2D). Central leptin sensitivity was also evaluated by introcereb-
roventricular (ICV) leptin administration. Chronic ICV infusion of
leptin caused a rapid reduction in body weight (Figure 2E) and
food intake (Figure 2F) in WT control mice but had minimal
effects on LRP1-KO mice (Figure 2E and 2F), suggesting that
LRP1 deletion led to leptin resistance.
In the arcuate nucleus of the hypothalamus, leptin regulates
energy imbalance by inhibiting expression of orexigenic neuropep-
tide Y (NPY) and agouti-related protein (AgRP) [13–17]. We found
that deletion of LRP1 markedly increased NPY and AgRP mRNA
levels in the hypothalamus (Figure 2G). Further, using immunoflu-
orescence staining, we demonstrated that LRP1 colocalized with
AgRP but not with POMC (Figure S3), suggesting that LRP1 may
specifically regulate leptin signaling in AgRP neurons. These results
are consistent with compromised leptin signaling in the hypothal-
amus of LRP1-KO mice and further support leptin signaling as the
potential mechanism by which LRP1 regulates food intake and
energy expenditure in the adult mice.
To further elucidate the molecular and cellular mechanisms
underlying LRP1 regulation of leptin signaling we used GT1-7
cells, a neuronal cell line derived from the mouse hypothalamus
[18]. LRP1 knockdown in GT1-7 cells by LRP1-specific siRNA
significantly decreased the phosphorylation of both Stat3 and
leptin receptor ObR (Figure 2H, 2I and S4A). While treatment of
control GT1-7 cells with leptin dramatically increased the
phosphorylation of both Stat3 and ObR, it only had lesser effects
on LRP1 knockdown cells (Figure 2H, 2I and S5). In addition, we
found that LRP1 knockdown significantly reduced the phosphor-
ylation of the extracellular signal-regulated kinase (ERK), which is
also downstream to the leptin receptor signaling (Figure S4B and
S4C) [19]. Previous studies have shown that the leptin receptor
mediates Stat3 phosphorylation via janus kinase 2 (JAK2)
activation [13–15]. Using co-immunoprecipitation, we confirmed
that LRP1 knockdown in GT1-7 cells decreased the interaction
between ObR and JAK2 (Figure 2J, S6A, S6B, S6D, and S7A).
We also found that LRP1 knockdown decreased leptin-mediated
phosphorylation of JAK2 (Figure S7B and S7C).
Because LRP1 had been previously shown to serve as co-
receptor to PDGF signaling via the PDGF receptor [4], we next
examined the potential for a direct association between LRP1 and
the leptin receptor. Using GT1-7 cellular extracts, we found that
the LRP1 antibody, but not a control antibody, co-immunopre-
cipitated the leptin receptor ObR in the presence of leptin but not
in the absence of leptin (Figure 2K, S6C, and S6E). To further
confirm direct binding of LRP1 to the leptin/leptin receptor
complex, we followed binding of
125I-leptin to GT1-7 cells with
chemical cross-linking [20]. Under these conditions, radiolabeled
leptin migrated as a high molecular weight complex on SDS-
PAGE that was immunoreactive with leptin, leptin receptor, and
LRP1 antibodies, but not with a control antibody or an antibody
to the LDL receptor (LDLR) (Figure 2L, S6F, and S8). The
specificity of each antibody in these co-immunoprecipitation
experiments was confirmed by antigen blocking. Together, these
results suggest that LRP1 regulates leptin signaling by forming a
complex with leptin and the leptin receptor.
Hypothalamic LRP1 Regulates Food Intake and Energy
Homeostasis
The hypothalamus is central to the control of food intake and
energy expenditure; therefore LRP1 deletion in the hypothalamus
Author Summary
The World Health Organization estimates that at least 1 in
10 adults worldwide are obese, and in some western
countries, a far greater percentage (25% or more) is
affected. Obesity is a serious concern because it increases
the risk of cardiovascular disease, type 2 diabetes, and
some cancers, among other health problems. Despite
recent advances in understanding the disease mechanism,
effective treatments are still lacking. Lipoprotein receptors
play critical roles in lipid metabolism, but their potential
roles in controlling food intake and obesity in the central
nervous system have not been examined. Here we show
that deletion of LRP1, a member of the LDL (low density
lipoprotein) receptor family, in the adult mouse brain
results in obese phenotype characterized by increased
food intake, decreased energy consumption and de-
creased leptin signaling. We further show that deletion
of the Lrp1 gene specifically in the hypothalamus (a region
of the brain) by using Cre lentivirus injection is sufficient to
trigger accelerated weight gain. Together, our results
present a novel function of LRP1: the direct regulation of
leptin signaling and energy balance in the adult central
nervous system. Hence, LRP1 represents a very promising
new therapeutic target for the design of innovative and
more effective therapies for obesity.
LRP1 Regulates Leptin Signaling and Energy Balance
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phenotype. To further test this hypothesis, we deleted the Lrp1
gene specifically in the hypothalamus using lentivirus delivery
technology (Figure 3A). Direct injection of Cre lentivirus into the
arcuate nucleus of the hypothalamus of Lrp1 floxp mice resulted in
significant neuronal LRP1 deletion, as measured by immunoflu-
orescence and Western blotting (Figure 3B–3E and S9) and
reduction of leptin signaling, as measured by reduced levels of P-
Stat3 (Figure 3D and 3E). Strikingly, Cre lentivirus-injected Lrp1
floxp mice also showed significantly greater body weight gain,
increased food intake, and higher fat content compared to control
GFP lentivirus-injected mice (Figure 3F–3H). Plasma levels of
leptin (Figure 3I) were significantly increased in Cre lentivirus-
injected mice. In addition, Cre lentivirus-injected mice had
markedly increased expression of NPY and AgRP (Figure 3J).
Cre lentivirus-injected mice also showed leptin insensitivity as
detected by impaired leptin-stimulated phosphorylation of hypo-
thalamic Stat3 (Figure S10A and S10B). As controls, Cre lentivirus
injection into either the cortical region of the Lrp1 floxp mice or
the arcuate nucleus of the hypothalamus in wild-type mice
(C57BL/6) did not result in accelerated weight gain (Figure 3K
and 3L).
Overexpression of LRP1 Rescues the Metabolic
Phenotype and Leptin Signaling
Having demonstrated that deletion of LRP1 led to obesity and
decreased leptin signaling, we were prompted to evaluate whether
overexpression of LRP1 could rescue the obese phenotype. Co-
expression of mLRP2, a functional LRP1 minireceptor [21],
reduced the body weight gain and ameliorated the hyperphagia
associated with hypothalamic cre overexpression in Lrp1 floxp
mice (Figure 4A and 4B). mLRP2 also partially restored leptin
Figure 1. Neuronal deletion of Lrp1 in the adult mouse brain leads to obesity associated with hyperlipidemia, glucose intolerance,
and insulin resistance. (A) Body weights of male LRP1-KO (Lrp1
flox+/+/Cre
+/2, LRP1 knockout) and WT (Lrp1
flox+/+/Cre
2/2, Lrp1 floxp littermate
control) mice were determined at the indicated ages (n=10, *p,0.05; **p,0.01). (B) A representative LRP1-KO mouse and a WT mouse at 12 mo of
age showing the obese phenotype associated with LRP1-KO. (C) Fat content in whole body assessed by magnetic resonance imaging (MRI) in LRP1-
KO and WT mice at 12 mo of age (n=8,*p,0.05). (D) Food intake of LRP1-KO and WT mice at 9 mo of age was determined daily over a 1-wk period
(n=7,*p,0.05). (E, F) Energy expenditure of LRP1-KO and WT mice at 13 mo of age was measured by O2 consumption (E) and CO2 production (F)
during both light cycle and dark cycle (n=6,*p,0.05). (G–J) Blood samples were obtained from overnight-fasted LRP1-KO and WT mice at 12 mo of
age and levels of free fatty acids (G), triglyceride (H), cholesterol (I), and insulin (J) were determined. For (G–J), n=9,*p,0.05; N.S., not significant. (K)
Glucose tolerance tests were performed on LRP1-KO and WT mice at 12 mo of age following 16 h of fasting (n=6,*p,0.05). (L) Insulin tolerance tests
were performed on LRP1-KO and WT mice at 12 mo of age following 6 h of fasting (n=7,*p,0.05). (M) Plasma leptin levels were determined by
ELISA on blood samples obtained from LRP1-KO and WT mice at 12 mo of age (n=10, *p,0.05). Error bars are mean 6 s.e.m.
doi:10.1371/journal.pbio.1000575.g001
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also involved in the obese phenotype of ob/ob mice. LRP1 protein
expression levels were significantly decreased in the hypothalamus
of ob/ob mice when compared to wild type mice (Figure S11A
and S11B). These results strongly support a critical role for LRP1
in leptin signaling in the hypothalamus.
Leptin binding to the long form of the leptin receptor (ObRb)
stimulates the tyrosine kinase JAK2 to phosphorylate Stat3
at tyrosine residues. P-Stat3 dimers subsequently enter the nucleus
and regulate transcription of target genes, such as AgRP and
POMC [13–15]. We found that LRP1 directly binds to leptin
and the leptin receptor complex and is required for leptin receptor
phosphorylation and Stat3 activation. Further, LRP1 knock-
down in GT1-7 cells decreased the interaction between leptin
receptor and JAK2, which reduced the leptin-mediated phos-
phorylation of JAK2. Interestingly, LRP1 is expressed in AgRP
Figure 2. LRP1 regulates leptin signaling. (A) Hypothalamic phosphorylated Stat3 (P-Stat3) was decreased in neuronal LRP1-KO mice. Levels of
P-Stat3 and total Stat3 in the hypothalamus of LRP1-KO and WT mice at 13 mo of age were evaluated by Western blotting. An equal amount of
sample protein was loaded in each lane in this and subsequent figures. (B) Densitometric quantification of P-Stat3 and total Stat3 levels was
performed as described in Materials and Methods (n=4,*p,0.05). (C) Deletion of LRP1 in adult brain led to decreased leptin sensitivity. LRP1-KO and
WT mice at 12 mo of age were injected intraperitoneally with leptin (1 mg/kg body weight) or PBS as control. Hypothalamic extracts were prepared
45 min after injection. Levels of LRP1, P-Stat3, and total Stat3 were analyzed by Western blotting. (D) Densitometric quantification of P-Stat3 and total
Stat3 levels was performed as described in Materials and Methods (n=4,*p,0.05; **p,0.01). (E, F) Effect of ICV leptin or artificial cerebrospinal fluid
(aCSF) infusion on body weight (E) and food intake (F) in LRP1-KO and WT mice at 12 mo of age (n=7). (G) Hypothalamic expression of genes
encoding neuropeptides was compared between LRP1-KO and WT mice at 13 mo of age (n=4, *p,0.05; **p,0.01; N.S., not significant) by
quantitative real-time RT-PCR. (H) GT1-7 cells were transiently transfected with control siRNA or LRP1-specific siRNA for 48 h, serum-starved
overnight, and then treated with 50 nM leptin or control for 30 min. Levels of LRP1, P-Stat3, total Stat3, and ObR were analyzed by Western blotting.
For P-ObR, extracts from GT1-7 cells were first immunoprecipitated with an anti-phosphotyrosine antibody and then immunoblotted with an anti-
ObR antibody. (I) Densitometric analysis of Western blot samples (n=4,*p,0.05; **p,0.01) indicates that knockdown of LRP1 greatly decreased the
ratio of P-Stat3/Stat3 and the ratio of P-ObR/ObR. (J) GT1-7 cells were transiently transfected with control siRNA or LRP1-specific siRNA for 48 h.
Extracts were prepared from GT1-7 cells and immunoprecipitated with either a control antibody or an anti-ObR antibody followed by
immunoblotting with an anti-JAK2 antibody. Extracts were also directly immunoblotted with the ObR antibody, JAK2 antibody, and LRP1 antibody.
(K) Extracts were prepared from GT1-7 cells and immunoprecipitated with either a control antibody or an anti-LRP1 antibody followed by
immunoblotting with an anti-ObR antibody. Extracts were also directly immunoblotted with the anti-ObR antibody and anti-LRP1 antibody.
(L) Ligand binding was performed by incubating GT1-7 cells with
125I-leptin for 1 h at 4uC. Chemical crosslinking was then carried out, followed by
immunoprecipitation with control antibody, anti-LRP1 antibody, anti-LRP1 antibody + full-length LRP1 protein, anti-leptin antibody, anti-leptin
antibody + leptin protein, anti-ObR antibody, anti-ObR antibody + specific blocking peptide, or anti-LDLR antibody, and immunoprecipitates were
analyzed on SDS-PAGE. Error bars are mean 6 s.e.m.
doi:10.1371/journal.pbio.1000575.g002
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cantly increases the expression of AgRP and NPY, indicating
that LRP1 deletion impairs lepitn signaling in AgRP neurons.
Taken together, our results suggest that LRP1 modulates leptin
signaling likely via regulation of JAK2 activation in AgRP
neurons.
It has been reported that leptin receptors are also expressed in
various cortical regions and hippocampus [22–23], which are
associated with learning and memory. In leptin receptor-deficient
mice, hippocampal CA1 region exhibits impaired long-term
potentiation (LTP) and long-term depression (LTD) [24], which
are widely considered major cellular mechanisms underlying
learning and memory. Further, leptin enhances NMDA receptor
function and modulates hippocampal synaptic plasticity [25].
LRP1 is also widely expressed in the cortex and hippocampus and
play essential roles in neurotransmission, and synaptic plasticity
[5–7]. LRP1 deletion in the cortex and hippocampus region may
also decrease leptin signaling and further affect synaptic function,
learning, and memory.
Neuronal inactivation of LRP1 achieved by expression of the
Cre transgene under control of the synapsin I promoter [26] has
been previously reported [27]. Unlike the CamKII-Cre model, in
which Lrp1 disruption was restricted to the forebrain and
hypothalamic areas, LRP1 deletion in the Syn-Cre model was
detectable much earlier and throughout the entire CNS, first
manifesting by impairment of motor function and systemic
tremors about 3 wk after birth. SynI-Cre/Lrp1 mutant mice were
also hyperphagic, but in contrast to the CamKII-Cre/Lrp1
Figure 3. Hypothalamic LRP1 regulates leptin signaling and body energy homeostasis. (A) Representative image demonstrating the
hypothalamus lentivirus injection technique. Arcuate nucleus of the hypothalamus of Rosa-26 reporter mice was bilaterally injected with Cre
lentivirus and then stained for LacZ. (B–J) Lrp1 floxp mice (Lrp1
flox+/+/Cre
2/2) at 8–10 wk of age were bilaterally injected with either Cre lentivirus or
control GFP lentivirus. Fourteen days after lentivirus injection, (B,C) double immunofluorescence staining was performed using either an anti-LRP1
antibody (detected with Alexa 568, red) and anti-NeuN antibody (detected with Alexa 488, green) (B) or an anti-LRP1 antibody (detected with Alexa
568, red) and anti-GFAP antibody (detected with Alexa 488, green) (C). A representative staining in ARC of hypothalamus is shown. (D) Levels of LRP1,
P-Stat3, total Stat3, and actin in the hypothalamus were analyzed by Western blotting. (E) Densitometric analyses of Western blot samples (n=4, *p
, 0.05; **p , 0.01) indicate that LRP1 deletion in the hypothalamus significantly decreased the ratio of P-Stat3/Stat3. (F, G) Body weight (F) and food
intake (G) were measured after lentivirus injection (n=5,*p , 0.05). (H) Fat content in whole body was compared between GFP control and Cre
lentivirus injected mice (n=4, *p , 0.05) by MRI. (I, J) Fourteen days after lentivirus injection, (I) plasma leptin levels were determined by ELISA on
blood samples (n=6,*p,0.05). (J) Hypothalamic expression of genes encoding neuropeptides was compared between Control and Cre lentivirus
injection mice (n=6,*p,0.05; N.S., not significant) by quantitative real-time PCR. (K) Lrp1 floxp mice were injected bilaterally into the cortex with
either Cre lentivirus or control GFP lentivirus (n=5, N.S., not significant). Body weight changes were measured 14 d after the lentivirus injection.
(L) Wild-type mice (C57BL/6) were injected bilaterally into the arcuate nucleus of hypothalamus with either Cre lentivirus or control GFP lentivirus
(n=5, N.S., not significant). Body weight changes were measured 14 d after the lentivirus injection. Error bars are mean 6 s.e.m.
doi:10.1371/journal.pbio.1000575.g003
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Lrp1 mice died prematurely between 6 and 9 mo of age. This
severe and earlier phenotype emphasized a critical role for CNS
LRP1 in motor circuitry and muscle control but effectively
occluded another pivotal role for LRP1 in the CNS, i.e., the
regulation of leptin signaling and metabolic homeostasis de-
scribed here.
In summary, we have uncovered a new molecular pathway that
regulates leptin signaling and energy homeostasis. Our results
demonstrate that LRP1, a lipoprotein receptor that plays important
roles inlipid metabolism,alsoregulatesfood intakeandbodyenergy
homeostasis in the CNS. Because ICV administration of apoE was
recently shown to suppress food intake in the rat [28], it is plausible
tospeculatethatbrainlipoproteinsmayalso playa role inregulating
food intake, l
ikely via LRP1. Interestingly, we found that LRP1 knockout
resulted in increased apoE levels in the hypothalamus (Figure S12),
consistent with the fact that apoE metabolism is impaired in the
LRP1 deficient mice. Therefore, LRP1 provides a critical link
between peripheral and central energy metabolism and could serve
as a novel therapeutic target to lessen obesity in human patients.
Materials and Methods
Materials
All tissue culture media and serum were from Sigma. Anti-
leptin receptor antibody was purchased from Santa Cruz, anti-
JAK2 antibody from Invitrogen, anti-phosphotyrosine antibody
from Upstate, anti-P-Stat3 and anti-Stat3 antibodies from Cell
Signaling, and anti-actin antibody from Sigma. In-house anti-
LRP1 antibody has been described previously [29–30].
Peroxidase-labeled anti-mouse antibody and ECL system were
from GE Healthcare. Carrier-free Na
125I was purchased from
Perkin Elmer Lifescience. Recombinant human insulin was
from Eli Lilly and recombinant mouse leptin was from R&D
Systems.
Food Intake and Metabolic Measurements
For feeding studies, animals were singly housed for 2 wk.
Food intake was measured daily for consecutive 7-d or 14-d
periods. Metabolic rates were measured by indirect calorimetry
(Windows Oxymax Equal Flow system, Columbus Instruments)
at the Washington University Diabetes Research and Training
Center (DRTC). Mice were housed individually in air-tight
respiratory cages through which room air was passed at a flow
rate of 0.51/min. O2 and CO2 contents of exhausted air were
determined by comparison with O2 and CO2 contents of
standardized sample air. VO2 and VCO2 were normalized to
lean body mass [31].
For GTT studies, mice were fasted overnight and D-glucose at
2 g/kg of body weight was injected intraperitoneally. Blood
glucose was monitored at 0, 15, 30, 60, 90, and 120 min
after glucose injection. Results were expressed as mean blood
glucose concentration from at least six animals per genotype. For
ITT studies, mice were fasted for 6 h and human insulin at 1 IU/
kg of body weight was injected intraperitoneally. Blood glucose
levels were monitored at 0, 15, 30, 60, and 120 min after insulin
injection. Results were expressed as mean percent of basal
Figure 4. LRP1 overexpression in LRP1 hypothalamic knockdown mice rescues leptin signaling and metabolic phenotype. (A–D) Lrp1
floxp mice were injected bilaterally in the hypothalamus with Cre lentivirus, Cre lentivirus plus mLRP2 lentivirus, or control GFP lentivirus. (A, B) Body
weight (A) and food intake (B) were measured after lentivirus injection (n=6,*p,0.05; **p,0.01). (C) Levels of mLRP2, P-Stat3, total Stat3, and actin
in the hypothalamus were analyzed by Western blotting. (D) Densitometric analyses of Western blot samples (n=4,*p,0.05; **p,0.01) indicate that
LRP1 deletion in the hypothalamus significantly decreased the ratio of P-Stat3/Stat3, which was rescued by mLRP2 overexpression. Error bars are
mean 6 s.e.m.
doi:10.1371/journal.pbio.1000575.g004
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genotype.
For leptin sensitivity, 12-mo-old mice were fasted for 24 h
and injected intraperitoneally with leptin (1 mg/kg body weight)
or PBS as control. Hypothalamic extracts were prepared 45
min after injection and immunoblotted with P-Stat3 and Stat3
antibody.
For chronic intracerebroventricular (ICV) infusion of leptin,
stereotaxic implantation of an intraventricular cannula to the third
ventricle of 12-mo-old mice was performed by the Washington
University Hope Center In Vivo Animal Models Core. After 1 wk,
an osmotic mini-pump (Alzet minipump) was attached to the ICV
catheter. The mini-pump delivered a constant infusion of leptin
(50 ng/h) or artificial cerebrospinal fluid (aCSF) for 14 d. Food
intake and body weight were monitored.
Body Fat Content
MRI, a whole-body magnetic resonance analyzer for mice
(Echo Medical Systems), was used to perform quantitative
magnetic resonance analysis of fat-free mass and fat mass. Fat
content was calculated as a percent of fat mass over the total body
mass.
Real-Time Reverse Transcriptase-Polymerase Chain
Reaction (RT-PCR)
RT-PCR analysis was performed as described previously [14].
Details can be found in Text S1.
Small Interfering RNA (siRNA)-Mediated Knockdown of
LRP1 in GT1-7 Cells
ON-TARGET plus
TM siRNA for LRP1 and control siRNA
were purchased from Dharmacon Research. Cells were transiently
transfected with 50 nM of the siRNA duplex using Lipofectamine
2000 (Invitrogen) according to the manufacturer’s instructions and
harvested for processing 48 h post-transfection.
Chemical Cross-Linking and Immunoprecipitation
Experiments were performed with
125I-leptin cross-linked to
unlabeled GT1-7 cells as described before [20]. Details can be
found in Text S1.
Western Blotting
Western blot analysis was performed as described previously
[20]. Details can be found in Text S1.
Plasma Lipid, Insulin, and Leptin Analyses
Venous blood was taken from 12-mo-old mice and centrifuged
at 7,000 rpm at 4uC for 5 min to separate plasma. Plasma FFAs,
TG, and cholesterol analyses were performed by the Washington
University DRTC. Serum leptin and insulin levels were also
measured by the DRTC using ELISA methods.
Generation of Lentivirus and Hypothalamus Injection
The lentivirus plasmids pHR’EF-Cre-WPRE-SIN and pHR-
EF-GFP-WPRE-SIN have been described previously [32]. Cre
lentivirus and GFP lentivirus were produced by the Washington
University Hope Center Viral Vectors Core. Eight to 10-wk-old
Rosa-26 reporter mice [33] or Lrp1 floxp mice were stereotaxically
injected with lentivirus into the arcuate nucleus of the hypothal-
amus (4 ml, 4.6610
8 TU/ml) with an air pressure injector system.
The injection was performed by the Washington University Hope
Center In Vivo Animal Models Core.
b-Gal Staining
Staining was performed as described previously [32]. Details
can be found in Text S1.
Immunofluorescence Staining
Staining was performed as described previously [14]. Details
can be found in Text S1.
Statistical Analysis
All data represent the average of at least triplicate samples.
Error bars represent standard error of the mean. Statistical
significance was determined by Student’s t test and p,0.05 was
considered significant.
Supporting Information
Figure S1 Lrp1 deletion in brain and peripheral tissues
in LRP1 forebrain knockout mice. (A–D) LRP1 expression
levels were compared between LRP1-KO (Lrp1
flox+/+/Cre
+/2,L R P 1
knockout) and WT (Lrp1
flox+/+/Cre
2/2, Lrp1 floxP littermate control)
mice at 3, 6, 9, and 12 mo of age by Western blotting. Densitometric
analysis of Western blots from multiple samples (n=4) indicated that
LRP1 expression was significantly reduced in an age-dependent
manner in the cortex (A), hypothalamus (B), and hippocampus (C),
but not in the cerebellum (D) of LRP1-KO mice. *p,0.05; **p,0.01;
N.S., not significant. For Panels A–D, data are presented as mean 6
s.e.m. (E) LRP1 expression levels in selected peripheral tissues were
compared between LRP1-KO and WT mice at 12 mo of age via
Western blotting. LRP1 expression levels were not significantly
altered in white adipose tissue, brown adipose tissue, pancreas, lung,
spleen, liver, heart, intestine, muscle, or kidney of LRP1-KO mice.
Found at: doi:10.1371/journal.pbio.1000575.s001 (1.34 MB TIF)
Figure S2 Neuronal deletion of Lrp1 in adult brain leads
to decreased leptin signaling and obesity. (A) Body weights
of female LRP1-KO and WT mice were determined at indicated
ages (n=10). *p,0.05; **p,0.01. (B) Neuronal deletion of Lrp1 in
adult brain did not change snout-anus length. Snout-anus length of
12-mo-old LRP1-KO and WT mice were measured (n=5,N.S.,not
significant). (C–D) Hypothalamic P-Stat3 levels were decreased in
neuronal LRP1-KO mice. (C) Levels of P-Stat3 and total Stat3 in the
hypothalamus of LRP1-KO and WT mice at 9 mo of age were
evaluated by Western blotting. (D) Densitometric quantification of P-
Stat3 and total Stat3 levels was performed as described in Materials
and Methods (n=4,*p,0.05). Data are presented as mean 6 s.e.m.
Found at: doi:10.1371/journal.pbio.1000575.s002 (0.25 MB TIF)
Figure S3 LRP1 is expressed in AgRP neurons but not in
POMC neurons of the mouse hypothalamus. Double
immunofluorescence staining was performed using an anti-LRP1
antibody (detected with Alexa 568, red) together with either an
anti-AgRP antibody or anti-MSH antibody (detected with Alexa
488, green). Representative staining images in mouse hypothala-
mus are shown. Note that LRP1 colocolized with AgRP but not
with POMC stained neurons.
Found at: doi:10.1371/journal.pbio.1000575.s003 (1.44 MB TIF)
Figure S4 LRP1 knockdown in GT1-7 cells decreases
Stat3 and ERK signaling. (A) GT1-7 cells were transiently
transfected with control siRNA or LRP1-specific siRNA for 48 h.
Levels of LRP1, P-Stat3, and total Stat3 were analyzed by
Western blotting. (B–C) LRP1 knockdown in GT1-7 cells reduced
ERK phosphorylation. (B) GT1-7 cells were transiently transfected
with HA-ObRb and control siRNA or LRP1-specific siRNAs for
48 h, serum-starved overnight, and then treated with 50 nM leptin
for 30 min. Levels of P-ERK1/2 and total ERK1/2 were analyzed
LRP1 Regulates Leptin Signaling and Energy Balance
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*p,0.05) indicated that LRP1 knockdown significantly reduced
the ratio of P-ERK/ERK. Data are shown as mean 6 s.e.m.
Found at: doi:10.1371/journal.pbio.1000575.s004 (0.35 MB
TIF)
Figure S5 LRP1 knockdown in GT1-7 cells decreases
Stat3 phosphorylation. (A) GT1-7 cells were transiently
transfected with control siRNA, LRP1-specific siRNA, and/or
HA-ObR cDNA for 48 h, serum-starved overnight, and then
treated with 50 nM leptin for 30 min. Levels of HA-ObR, P-
Stat3, and total Stat3 were analyzed by Western blotting. (B)
Densitometric analysis of blots (n=4, **p,0.01, *p,0.05)
indicated that ObR overexpression alone increased the ratio of
P-Stat3/Stat3 and that LRP1 knockdown markedly reduced
leptin-mediated increase of P-Stat3/Stat3. Data are shown as
mean 6 s.e.m.
Found at: doi:10.1371/journal.pbio.1000575.s005M (0.31 MB
TIF)
Figure S6 LRP1 interacts with leptin and leptin receptor
complex. (A) Levels of ObR and actin in the hypothalamus of
wild-type and db/db mice (Jackson lab) at 12 wk of age were
evaluated by Western blotting. (B) Cellular extracts were prepared
from GT1-7 cells and immunoprecipitated with either a control
antibody or an anti-JAK2 antibody followed by immunoblotting
with an anti-ObR or anti-JAK2 antibody. Extracts were also
directly immunoblotted with the ObR antibody and JAK2
antibody. (C) Cellular extracts prepared from GT1-7 cells were
immunoprecipitated with either a control antibody or an anti-
ObR antibody, followed by immunoblotting with an anti-LRP1 or
anti-ObR antibody. Extracts were also directly immunoblotted
with the ObR antibody and LRP1 antibody. (D) Extracts were
prepared from GT1-7 cells and immunoprecipitated with either an
anti-JAK2 antibody or an anti-JAK2 antibody with specific
blocking peptide, followed by immunoblotting with an anti-ObR
or anti-JAK2 antibody. Extracts were also directly immunoblotted
with the ObR antibody and JAK2 antibody. (E) Extracts were
prepared from GT1-7 cells and immunoprecipitated with either an
anti-ObR antibody or an anti-ObR antibody with specific
blocking peptide, followed by immunoblotting with an anti-
LRP1 or anti-ObR antibody. Extracts were also directly
immunoblotted with the ObR antibody and LRP1 antibody. (F)
Densitometric quantification of immunoreactive bands from
Figure 2L was performed as described in Materials and Methods
(n=4, N.S., not significant).
Found at: doi:10.1371/journal.pbio.1000575.s006 (0.71 MB TIF)
Figure S7 LRP1 knockdown in GT1-7 cells decreases
JAK2 phosphorylation. (A) GT1-7 cells were transiently
transfected with HA-ObRb for 48 h, serum-starved overnight,
and then treated with 50 nM leptin or vehicle control for 30 min.
Extracts were prepared from GT1-7 cells and immunoprecipitated
with an anti-HA antibody followed by immunoblotting with an
anti-JAK2 antibody. Extracts were also directly immunoblotted
with the HA antibody, JAK2 antibody, and Actin antibody. (B)
GT1-7 cells were transiently transfected with control siRNA,
LRP1-specific siRNA, and/or HA-ObR for 48 h, serum-starved
overnight, and then treated with 50 nM leptin for 30 min. Levels
of P-JAK2 and total JAK2 were analyzed by Western blotting. (C)
Densitometric analysis of blots (n=4, **p,0.01, *p,0.05)
indicated that, similar to Stat3, ObR overexpression alone
increased the ratio of P-JAK2/JAK2 and that LRP1 knockdown
reduced leptin-mediated increase of P-JAK2/JAK2. Data are
shown as mean 6 s.e.m.
Found at: doi:10.1371/journal.pbio.1000575.s007 (0.37 MB TIF)
Figure S8 LRP1 is directly associated with the leptin/
leptin receptor complex. (A) GT1-7 cells were transiently
transfected with control or HA-ObR for 48 h. Ligand binding was
performed by incubating GT1-7 cells with
125I-leptin for 1 h at
4uC. Chemical crosslinking was carried out, followed by
immunoprecipitation with control antibody, anti-LRP1 antibody,
anti-leptin antibody, anti-HA antibody, and immunoprecipitates
were analyzed on SDS-PAGE. (B) Densitometric quantification of
immunoreactive bands from (A) was performed as described in
Materials and Methods (n=4, N.S., not significant).
Found at: doi:10.1371/journal.pbio.1000575.s008 (0.39 MB TIF)
Figure S9 Cre lentivirus injection into the hypothala-
mus of the Lrp1 floxp mice leads to LRP1 deletion. Lrp1
floxp mice (Lrp1
flox+/+/Cre
2/2) mice were bilaterally injected into
ARC of the hypothalamus with either Cre lentivirus or control
GFP lentivirus. Fourteen days after lentivirus injection, immuno-
fluorescence staining was performed using an anti-LRP1 antibody
(detected with Alexa 488, green) and a representative staining in
ARC of hypothalamus is shown.
Found at: doi:10.1371/journal.pbio.1000575.s009 (0.81 MB TIF)
Figure S10 Cre lentivirus injection into Lrp1 floxp mice
leads to decreased leptin sensitivity. Lrp1 floxp mice were
bilaterally injected with either Cre lentivirus or control GFP
lentivirus. (A) Fourteen days after lentivirus injection, Lrp1 floxp
mice were injected intraperitoneally with leptin (1 mg/kg body
weight) or PBS as control. Hypothalamic extracts were prepared
45 min after injection. Levels of P-Stat3 and total Stat3 were
analyzed by Western blotting. (B) Densitometric quantification of
P-Stat3 and total Stat3 levels was performed as described in
Materials and Methods (n=4,*p,0.05; **p,0.01).
Found at: doi:10.1371/journal.pbio.1000575.s010 (0.18 MB TIF)
Figure S11 LRP1 expression levels are significantly
decreased in ob/ob mice. (A) LRP1 expression levels in the
hypothalamus were compared between WT and ob/ob mice at 4
mo of age by Western blotting. LRP1 expression levels were
significantly decreased in the hypothalamus of ob/ob mice. (B)
Densitometric analysis of Western blot samples (n=4,*p,0.05).
Found at: doi:10.1371/journal.pbio.1000575.s011 (0.11 MB TIF)
Figure S12 LRP1 deletion increases apoE levels in the
hypothalamus. ApoE levels were measured in hypothalamic
lysates of 13-mo-old WT and LRP1-KO mice (n=5), normalized
against total protein, and plotted as a percentage of WT controls.
*p,0.05.
Found at: doi:10.1371/journal.pbio.1000575.s012 (0.05 MB TIF)
Text S1 Supplementary experimental procedures.
Found at: doi:10.1371/journal.pbio.1000575.s013 (0.04MBDOC)
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